Risk prediction models of breast cancer: a systematic review of model performances
Role of interleukin-10 in breast cancer
Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer
Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1
Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N -methyl- N -nitrosourea-induced rat mammary carcinoma model and its effects on the uterus
Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer
Genetic heterogeneity in HER2 testing may influence therapy eligibility
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues
Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients
Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis
Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment
Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04)
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer
Prospective study of breast tomosynthesis as a triage to assessment in screening
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin
Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
Disparities in breast cancer care delivery: solving a complex puzzle
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers
Favorable outcome associated with an IGF-1 ligand signature in breast cancer
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO
Willingness to use tamoxifen to prevent breast cancer among diverse women
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
Social networks, social support and burden in relationships, and mortality after breast cancer diagnosis
Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
Not so fast: the use of incomplete data to devalue the role of mammography screening
Erratum to: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis